The Responsible Biotics Framework™
The Responsible Biotics Framework™
Five principles for developing animal microbiome and probiotic products that work, comply, and last.
The Origin of The Framework
You know WHAT nobody tells you when you're launching an animal probiotic product?
It is not the science... And believe me the science is the easy part!
After spending years in different countries while trying to formulate, manufacture and launch them; I realized a pattern. A looking-fine but effecting-huge pattern: brilliant science, terrible execution.
A company develops a probiotic and manufactures. The marketing team writes beautiful claims. The product launches. And six months later, someone realizes the strain was never validated for that species, the label language crosses into drug-claim territory, or the manufacturing process killed half the viable organisms before the bag was even sealed!
I can say that all of these people had good intentions. They made real investment. They had teams of smart people. But still... the products kept failing. Or worse! It doesn't fail visibly and sits on shelves with the promises that science could never support. I stopped treating these as isolated problems a long time ago. They are all symptoms of the same thing: we are commercializing complexity faster than we are understanding it.
So I built a framework. This is a way of thinking about biotics development with five steps. Kind of five filters. If a product can't pass all five, believe me it's not ready!
THE FIVE PRINCIPLES
Mechanistic Validity
Species-Specific Evidence
Regulatory Alignment
Manufacturing Integrity
Post-Market Accountability
Know why it works. Not just that it works.
The animal health market is full of products with clinical trial results that show "something happened" but can't explain the mechanism behind it. A dog's stool improved. A chicken gained more weight. Great. But why?
If you can't explain the mechanism of action, you can't predict what happens in a different species, a different dose, a different production environment, or a different regulatory jurisdiction. You're guessing. And the moment someone asks you to prove your claims in front of a regulator or an attorney, "it worked in our trial" is not enough.
We need to start with this question: what is the biological mechanism? If we can identify the pathway, whether it's competitive exclusion, SCFA production, immune modulation, barrier function support, or something else, we can build a product that works across markets, across species, and across time. If we can't, we stop and figure it out before anything else moves forward.
What works in chickens does not automatically work in dogs!
I've reviewed product dossiers where the entire efficacy argument was based on studies done in a completely different animal species. A Lactobacillus strain validated in broiler chickens, now being marketed specifically for senior dogs. And Bacillus strain with good ruminant data, repackaged for aquaculture.
The gut anatomy is different. The microbiome composition is different. The immune system architecture is different. The transit time, pH, feed matrix... all different. Extrapolation without data is not science. I'd call it just hope with a product label on it.
If the data -evidence in target species- doesn't exist yet, you have to design the right studies to generate it. I will be clear - if you skip this step, you're building on sand and I cannot promise that you will still be in business five years later.
The compliance into the product needs to be built from day one.
There is a saying in Turkish: 'Bugunun isini yarina birakma' (Don't put off for tomorrow what you can do today). I can't count how many times I've been called in after a product was already formulated, labeled, and halfway to market... and someone (finally) asked, "Wait, is this FDA-compliant?"
By that point, the label language has drug claims in it. The ingredient doesn't have a recognized pathway. The manufacturing facility hasn't addressed GMP requirements specific to live organisms.
Can it be fixed? Well... if you redesign it, yes!
Regulatory alignment means involving someone who understands the regulatory landscape from the very first conversation about the product. You need somebody to help you before the formulation is locked, label is designed, marketing copy is written... You also need to train your team (all teams from all departments) about your products and the mechanism behind it.
Regulatory pathway and the product development pathway are (and should always be) parallel tracks, not sequential ones. The companies that get this right save months of rework and tens of thousands of dollars in corrections.
A great strain means nothing with a poor production.
A company invests two years selecting the perfect probiotic strain. The in vitro data is beautiful. The animal trials show real results. And then the commercial-scale manufacturing process kills 60% of the viable organisms before the product ships.
Or the strain survives production but dies during storage or transportation because nobody tested stability under real-world conditions. Or the encapsulation technology works at lab scale but fails at commercial volumes. Or the supplier changes a carrier ingredient and nobody retests viability...
Manufacturing integrity means the strain that showed efficacy in the study is the same strain, at the same viable count, that reaches the animal's gut. That requires validated production processes, real stability data (not accelerated projections), proper quality control at every step, and an honest CFU guarantee at end of shelf life, not at time of manufacture.
You should look for the gap between "what the study proved" and "what the customer actually receives!"
The product launch is the beginning - don't act like you are at the finish line.
Most of the industry treats market launch as the final milestone. The celebrations happen, the press release goes out, and everyone moves on to the next project.
But the animal using that probiotic today is not a study subject in a controlled environment. It's a real dog in a real home with a real owner who is making health decisions based on what your label promises. Or it's a flock of 30,000 broilers and the farmer's entire livelihood depends on that product performing as advertised.
Post-market accountability means monitoring real-world outcomes. It means having systems to collect and respond to adverse event reports. It means updating label claims when new evidence emerges. It means pulling a product or reformulating when the data says you should, even when the sales numbers say otherwise.
A friendly advice: Your reputation is not built by the products you launch. It's built by what you do after you launch them.
